13F Notebook
← Dashboard
Fund detail

Viking Global Investors (Halvorsen)

hedge-fund, active

Quarters 52
2021-09-30 $36.46B
Positions 96
Showing 11 of 11 rows (filtered from 114)

Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.

# Issuer Value ↓ Weight Shares Share Δ Share Δ % Prev Weight First Held Price Est. Cost Unrealized % Status
1 BRIDGEBIO PHARMA INC BBIO $1.25B 3.42% 26,620,991 +0 +0.00% 4.92% 2019-06-30 $47 ~$27 +73.79%
2 ADAPTIVE BIOTECHNOLOGIES COR ADPT $1.02B 2.80% 29,993,708 +0 +0.00% 3.72% 2019-06-30 $34 ~$48 -29.63%
3 API GROUP CORP APG $678.3M 1.86% 33,333,333 +0 +0.00% 2.11% 2020-06-30 $20 ~$12 +67.49%
4 INHIBRX INC INBXUSD $176.7M 0.48% 5,305,866 +0 +0.00% 0.44% 2020-09-30 $33 ~$18 +85.05%
5 4D MOLECULAR THERAPEUTICS IN FDMT $106.2M 0.29% 3,937,914 +0 +0.00% 0.29% 2020-12-31 $27 ~$41 -34.93%
6 PMV PHARMACEUTICALS INC PMVP $53.4M 0.15% 1,790,284 +0 +0.00% 0.19% 2020-09-30 $30 ~$35 -16.06%
7 EDGEWISE THERAPEUTICS INC EWTX $45.3M 0.12% 2,727,249 +0 +0.00% 0.18% 2021-03-31 $17 ~$32 -48.92%
8 TALARIS THERAPEUTICS INC $44.6M 0.12% 3,289,617 +0 +0.00% 0.15% 2021-06-30 $14 ~$15 -7.69%
9 KINNATE BIOPHARMA INC KNTEUSD $41.9M 0.11% 1,820,462 +0 +0.00% 0.13% 2020-12-31 $23 ~$40 -42.13%
10 PHARVARIS N V $41.3M 0.11% 2,391,517 +0 +0.00% 0.13% 2021-03-31 $17 ~$28 -38.52%
11 SMART SH GLOBAL LTD EM $1.6M 0.00% 470,000 +0 +0.00% 0.01% 2021-06-30 $3 ~$6 -44.97%